YOUR FRIENDS' ACTIVITY

    Biotech News Headlines

    • The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva
      Swiss billionaires buy Merck Serono HQ for biotech campus Caroline Copley - Reuters - Wed, May 22, 2013

      By Caroline Copley ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish … More »Swiss billionaires buy Merck Serono HQ for biotech campus

      The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva

      By Caroline Copley ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus. After selling the family business to German drugmaker Merck KGaA for $13.3 billion in 2006, the Harvard Business School graduate …

    • A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL's School of Pharmacy in London
      UK tries out new model for gene testing in cancer patients Kate Kelland - Reuters - Mon, May 20, 2013

      By Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to have access to the kind of genetic … More »UK tries out new model for gene testing in cancer patients

      A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL's School of Pharmacy in London

      By Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to have access to the kind of genetic analysis that led Hollywood star Angelina Jolie to decide to undergo a double mastectomy. The project, involving the Institute of Cancer Research (ICR) in …

    • Affymetrix CFO Barabe to retire in June AP - Mon, May 20, 2013

      Affymetrix Chief Financial Officer Tim Barabe is planning to retire from his post next month. The genetic testing instrument business said Monday that it is promoting … More »Affymetrix CFO Barabe to retire in June

      Affymetrix Chief Financial Officer Tim Barabe is planning to retire from his post next month. The genetic testing instrument business said Monday that it is promoting Gavin Wood to the position. Barabe's ...

    • This undated image made available by the Oregon Health & Science University in May 2013 shows developing cloned human embryos. Scientists have finally recovered stem cells from cloned human embryos, a longstanding goal that could lead to new treatments for such illnesses as Parkinson's disease and diabetes. In the Wednesday, May 15, 2013 edition of the journal Cell, scientists at the Oregon Health & Science University report harvesting stem cells from six embryos. Shoukhrat Mitalipov, who led the research, said the success came not from a single technical innovation, but from revising a series of steps in the process. (AP Photo/Oregon Health & Science University)
      Stem cells recovered from cloned human embryos MALCOLM RITTER - AP - Wed, May 15, 2013

      NEW YORK (AP) — Scientists have finally recovered stem cells from cloned human embryos, a longstanding goal that could lead to new treatments for such illnesses as Parkinson's … More »Stem cells recovered from cloned human embryos

      This undated image made available by the Oregon Health & Science University in May 2013 shows developing cloned human embryos. Scientists have finally recovered stem cells from cloned human embryos, a longstanding goal that could lead to new treatments for such illnesses as Parkinson's disease and diabetes. In the Wednesday, May 15, 2013 edition of the journal Cell, scientists at the Oregon Health & Science University report harvesting stem cells from six embryos. Shoukhrat Mitalipov, who led the research, said the success came not from a single technical innovation, but from revising a series of steps in the process. (AP Photo/Oregon Health & Science University)

      NEW YORK (AP) — Scientists have finally recovered stem cells from cloned human embryos, a longstanding goal that could lead to new treatments for such illnesses as Parkinson's disease and diabetes.

    • Scientists Report First Success in Cloning Human Stem Cells Alice Park - Time.com - Wed, May 15, 2013

      It’s been 17 years since Dolly the sheep was cloned from a mammary cell. And now scientists applied the same technique to make the first embryonic-stem-cell lines from … More »Scientists Report First Success in Cloning Human Stem Cells

      It’s been 17 years since Dolly the sheep was cloned from a mammary cell. And now scientists applied the same technique to make the first embryonic-stem-cell lines from human skin cells.

    • This Friday, May 10, 2013 photo shows a genetically engineered potato poking through the soil of a planting pot inside J.R. Simplot's lab in southwestern Idaho. Simplot is seeking U.S. regulatory approval to market the potatoes _ which resist browning and are designed to produce lower levels of potentially cancer-causing acrylamide when fried _ to growers and, eventually, consumers. (AP Photo/John Miller)
      Idaho spud giant bets on biotech potatoes JOHN MILLER - AP - Tue, May 14, 2013

      BOISE, Idaho (AP) — A dozen years after a customer revolt forced Monsanto to ditch its genetically engineered potato, an Idaho company aims to resurrect high-tech sp … More »Idaho spud giant bets on biotech potatoes

      This Friday, May 10, 2013 photo shows a genetically engineered potato poking through the soil of a planting pot inside J.R. Simplot's lab in southwestern Idaho. Simplot is seeking U.S. regulatory approval to market the potatoes _ which resist browning and are designed to produce lower levels of potentially cancer-causing acrylamide when fried _ to growers and, eventually, consumers. (AP Photo/John Miller)

      BOISE, Idaho (AP) — A dozen years after a customer revolt forced Monsanto to ditch its genetically engineered potato, an Idaho company aims to resurrect high-tech spuds.

    • Handout photo showing the extraction of the nucleus from an egg cell
      Scientists create human stem cells through cloning Sharon Begley - Reuters - Wed, May 15, 2013

      By Sharon Begley NEW YORK (Reuters) - After more than 15 years of failures by scientists around the world and one outright fraud, biologists have finally created human … More »Scientists create human stem cells through cloning

      Handout photo showing the extraction of the nucleus from an egg cell

      By Sharon Begley NEW YORK (Reuters) - After more than 15 years of failures by scientists around the world and one outright fraud, biologists have finally created human stem cells by the same technique that produced Dolly the cloned sheep in 1996: They transplanted genetic material from an adult cell into an egg whose own …

    • FDA approves genetic test for lung cancer drug AP - Tue, May 14, 2013

      The Food and Drug Administration on Tuesday approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by the company's … More »FDA approves genetic test for lung cancer drug

      The Food and Drug Administration on Tuesday approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by the company's Genentech unit. The diagnostic ...

    • Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz
      FDA approves Roche diagnostic for gene mutation in lung cancer Reuters - Tue, May 14, 2013

      (Reuters) - U.S. health regulators on Tuesday approved a test developed by Roche for a specific gene mutation present in about 10 percent of non-small cell lung cancers, … More »FDA approves Roche diagnostic for gene mutation in lung cancer

      Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz

      (Reuters) - U.S. health regulators on Tuesday approved a test developed by Roche for a specific gene mutation present in about 10 percent of non-small cell lung cancers, and said the company's drug Tarceva could be used as an initial treatment in patients with the mutation whose cancer has spread beyond the lungs. This …

    • Prostate cancer patient Dean Smith, left, a retired marketing executive, meets with Dr. Peter Carroll, right, at the UCSF Medical Center in San Francisco on Thursday, May 2, 2013. Carroll, chairman of urology at the University of California, San Francisco says a study he led on a new prostate cancer test - the Oncotype DX Genomic Prostate Score - suggested it could triple the number of men known to be at such low risk for aggressive disease that monitoring is a clearly safe option. Conversely, the test also suggested that some tumors were more aggressive than doctors had believed. (AP Photo/Eric Risberg)
      Gene test may help guide prostate cancer treatment MARILYNN MARCHIONE - AP - Wed, May 8, 2013

      A new genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away … More »Gene test may help guide prostate cancer treatment

      Prostate cancer patient Dean Smith, left, a retired marketing executive, meets with Dr. Peter Carroll, right, at the UCSF Medical Center in San Francisco on Thursday, May 2, 2013. Carroll, chairman of urology at the University of California, San Francisco says a study he led on a new prostate cancer test - the Oncotype DX Genomic Prostate Score - suggested it could triple the number of men known to be at such low risk for aggressive disease that monitoring is a clearly safe option. Conversely, the test also suggested that some tumors were more aggressive than doctors had believed. (AP Photo/Eric Risberg)

      A new genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it.

    • News Summary: Gene test may help cancer treatment The Associated Press - AP - Wed, May 8, 2013

      BREAKTHROUGH: A new genetic test to gauge the aggressiveness of prostate cancer may help men decide whether they need to treat their cancer right away or can safely monitor … More »News Summary: Gene test may help cancer treatment

      BREAKTHROUGH: A new genetic test to gauge the aggressiveness of prostate cancer may help men decide whether they need to treat their cancer right away or can safely monitor it. PROVIDING ANSWERS: Doctors ...

    • FILE - In this Feb. 4, 2006, file photo, IOC medical commission chairman Arne Ljungqvist responds to a question during a press conference on doping test on Austrian athletes, in Turin, Italy. Olympic officials and scientific experts will meet in in Beijing, China on June 5-6, 2013, to review the progress in developing a test for gene doping, the potential future of cheating in sports. (AP Photo/Kevork Djansezian, File)
      WADA to hold meeting in China on gene doping STEPHEN WILSON - AP - Fri, May 3, 2013

      LONDON (AP) — Olympic officials and scientific experts will meet in China next month to review the progress in developing a test for gene doping, the potential future … More »WADA to hold meeting in China on gene doping

      FILE - In this Feb. 4, 2006, file photo, IOC medical commission chairman Arne Ljungqvist responds to a question during a press conference on doping test on Austrian athletes, in Turin, Italy. Olympic officials and scientific experts will meet in in Beijing, China on June 5-6, 2013, to review the progress in developing a test for gene doping, the potential future of cheating in sports. (AP Photo/Kevork Djansezian, File)

      LONDON (AP) — Olympic officials and scientific experts will meet in China next month to review the progress in developing a test for gene doping, the potential future of cheating in sports.

    • NY biotech financier gets prison for stock scheme Larry Neumeister, Associated Press - AP - Thu, May 2, 2013

      A federal judge displayed anger as she handed down a four-year prison sentence Thursday to a biotechnology financier who was once among the nation's wealthiest people. … More »NY biotech financier gets prison for stock scheme

      A federal judge displayed anger as she handed down a four-year prison sentence Thursday to a biotechnology financier who was once among the nation's wealthiest people. U.S. District Judge Colleen McMahon ...

    • Judge gives onetime 'King of Biotech' 4 years in prison Nate Raymond - Reuters - Thu, May 2, 2013

      By Nate Raymond NEW YORK (Reuters) - A once prominent biotechnology investor was handed four years in prison on Thursday after pleading guilty to stock manipulation, … More »Judge gives onetime 'King of Biotech' 4 years in prison

      By Nate Raymond NEW YORK (Reuters) - A once prominent biotechnology investor was handed four years in prison on Thursday after pleading guilty to stock manipulation, the second time he has run afoul of U.S. securities laws. David Blech, 57, pleaded guilty in May 2012 to securities fraud charges stemming from improper trades …

    • Good Reads: Mars mission, gene patents, cellphone tracking, 'absurd' start-ups, Netflix streamlines Chris Gaylord - Christian Science Monitor - Wed, May 1, 2013

      Dutch entrepreneur Bas Lansdorp says he will establish a human colony on Mars within 10 years. The technology already exists, he says, but current missions have the wrong … More »Good Reads: Mars mission, gene patents, cellphone tracking, 'absurd' start-ups, Netflix streamlines

      Dutch entrepreneur Bas Lansdorp says he will establish a human colony on Mars within 10 years. The technology already exists, he says, but current missions have the wrong business model. Don’t copy space agencies, he says. Copy the Olympics.

    • In this July 13, 2012 photo, Hannah Warren, 2, poses with her parents Lee Young-mi and Darryl Warren at Seoul National University Hospital in Seoul, South Korea. Hannah received a new windpipe made from her own stem cells in a landmark operation on April 9, 2013, at Children's Hospital of Illinois in Peoria, Ill. She is the youngest patient ever to get the experimental treatment. Hannah was born without a windpipe and her doctors in South Korea expected her to die, but doctors in Illinois said Tuesday, April 30, 2013, she is recovering and likely will lead a normal life. (AP Photo/The Korea Herald, Kim Myung-sub) KOREA OUT, EDITORIAL USE ONLY
      2-year-old girl gets windpipe made from stem cells LINDSEY TANNER - AP - Tue, Apr 30, 2013

      CHICAGO (AP) — A 2-year-old girl born without a windpipe now has a new one grown from her own stem cells, the youngest patient in the world to benefit from the experimental … More »2-year-old girl gets windpipe made from stem cells

      In this July 13, 2012 photo, Hannah Warren, 2, poses with her parents Lee Young-mi and Darryl Warren at Seoul National University Hospital in Seoul, South Korea. Hannah received a new windpipe made from her own stem cells in a landmark operation on April 9, 2013, at Children's Hospital of Illinois in Peoria, Ill. She is the youngest patient ever to get the experimental treatment. Hannah was born without a windpipe and her doctors in South Korea expected her to die, but doctors in Illinois said Tuesday, April 30, 2013, she is recovering and likely will lead a normal life. (AP Photo/The Korea Herald, Kim Myung-sub) KOREA OUT, EDITORIAL USE ONLY

      CHICAGO (AP) — A 2-year-old girl born without a windpipe now has a new one grown from her own stem cells, the youngest patient in the world to benefit from the experimental treatment.

    • New gene therapy trials aim to mend broken hearts Ben Hirschler - Reuters - Mon, Apr 29, 2013

      By Ben Hirschler LONDON (Reuters) - British scientists are stepping up clinical tests of gene therapy in a bid to help people with advanced heart failure pump blood more … More »New gene therapy trials aim to mend broken hearts

      By Ben Hirschler LONDON (Reuters) - British scientists are stepping up clinical tests of gene therapy in a bid to help people with advanced heart failure pump blood more efficiently. Researchers said on Tuesday they planned to enroll patients into two new clinical trials using Mydicar, a gene therapy treatment made by privately …

    • Cowen upbeat on Nanosphere; shares rise AP - Mon, Apr 22, 2013

      Shares of genetic testing products maker Nanosphere Inc. climbed Monday after a Cowen & Co. analyst rated its stock "Outperform." THE SPARK: Analyst Shaun Rodriguez is … More »Cowen upbeat on Nanosphere; shares rise

      Shares of genetic testing products maker Nanosphere Inc. climbed Monday after a Cowen & Co. analyst rated its stock "Outperform." THE SPARK: Analyst Shaun Rodriguez is optimistic about the company's ...

    • Employees dispose uninfected dead birds at a treatment plant as part of preventive measures against the H7N9 bird flu in Guangzhou
      Gene data show China bird flu mutated "under the radar" Kate Kelland - Reuters - Fri, Apr 19, 2013

      By Kate Kelland LONDON (Reuters) - The new strain of bird flu that has killed 17 people in China has been circulating widely "under the radar" and has acquired significant … More »Gene data show China bird flu mutated "under the radar"

      Employees dispose uninfected dead birds at a treatment plant as part of preventive measures against the H7N9 bird flu in Guangzhou

      By Kate Kelland LONDON (Reuters) - The new strain of bird flu that has killed 17 people in China has been circulating widely "under the radar" and has acquired significant genetic diversity that makes it more of a threat, scientists said on Friday. Dutch and Chinese researchers who analyzed genetic data from seven samples …

    • Minn. floats $15.4M in subsidies for biotech firm Brian Bakst, Associated Press - AP - Thu, Apr 18, 2013

      State leaders stand ready to commit up to $15.4 million in taxpayer subsidies to a Fortune 500 pharmaceutical company they hope will put an outpost in Minnesota, according … More »Minn. floats $15.4M in subsidies for biotech firm

      State leaders stand ready to commit up to $15.4 million in taxpayer subsidies to a Fortune 500 pharmaceutical company they hope will put an outpost in Minnesota, according to a document made public Wednesday. ...

    • Minn. may aid biotech firm after covert courtship Brian Bakst, Associated Press - AP - Wed, Apr 17, 2013

      Following a hush-hush courtship, top Minnesota lawmakers acknowledged Tuesday that they are compiling a multi-million dollar package of public subsidies and tax breaks … More »Minn. may aid biotech firm after covert courtship

      Following a hush-hush courtship, top Minnesota lawmakers acknowledged Tuesday that they are compiling a multi-million dollar package of public subsidies and tax breaks to encourage an Illinois-based pharmaceutical ...

    • People walk in front of the Supreme Court building in Washington
      Justices wary of wide human gene patent ruling Lawrence Hurley - Reuters - Mon, Apr 15, 2013

      By Lawrence Hurley WASHINGTON (Reuters) - The Supreme Court justices on Monday signaled reluctance to issue too broad a ruling about patents on human genes, and some … More »Justices wary of wide human gene patent ruling

      People walk in front of the Supreme Court building in Washington

      By Lawrence Hurley WASHINGTON (Reuters) - The Supreme Court justices on Monday signaled reluctance to issue too broad a ruling about patents on human genes, and some indicated they might seek a compromise distinguishing between types of genetic material. The biotechnology industry has warned that an expansive ruling against …

    • A view shows the headquarters of Life Technologies Corp in Carlsbad
      Thermo Fisher to buy Life Tech for $13.6 billion Bill Berkrot and Susan Kelly - Reuters - Mon, Apr 15, 2013

      By Bill Berkrot and Susan Kelly NEW YORK (Reuters) - Thermo Fisher Scientific Inc on Monday agreed to buy Life Technologies Corp for $13.6 billion in a deal that would … More »Thermo Fisher to buy Life Tech for $13.6 billion

      A view shows the headquarters of Life Technologies Corp in Carlsbad

      By Bill Berkrot and Susan Kelly NEW YORK (Reuters) - Thermo Fisher Scientific Inc on Monday agreed to buy Life Technologies Corp for $13.6 billion in a deal that would make it one of the top two companies in the hot field of genetic testing. The pact values Life Tech at $76 per share, a 12 percent premium, and is one of …

    • Health officers examine a pigeon for H7N9 at a poultry market in Changsha
      Analysis: Gene swapping makes new China bird flu a moving target Kate Kelland, Health and Science Correspondent - Reuters - Mon, Apr 15, 2013

      By Kate Kelland, Health and Science Correspondent LONDON (Reuters) - A new bird flu virus that has killed 13 people in China is still evolving, making it hard for scientists … More »Analysis: Gene swapping makes new China bird flu a moving target

      Health officers examine a pigeon for H7N9 at a poultry market in Changsha

      By Kate Kelland, Health and Science Correspondent LONDON (Reuters) - A new bird flu virus that has killed 13 people in China is still evolving, making it hard for scientists to predict how dangerous it might become. Influenza experts say the H7N9 strain is probably still swapping genes with other strains, seeking to select …

    • Thermo Fisher reportedly nears deal for Life Tech AP - Sun, Apr 14, 2013

      Thermo Fisher Scientific Inc. is reportedly nearing a deal to buy Life Technologies Corp., a maker of genetic testing equipment, for almost $12 billion. Thermo Fisher's … More »Thermo Fisher reportedly nears deal for Life Tech

      Thermo Fisher Scientific Inc. is reportedly nearing a deal to buy Life Technologies Corp., a maker of genetic testing equipment, for almost $12 billion. Thermo Fisher's bid for Life Technologies topped ...

     

    Follow Yahoo! News